KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Equity Average (2016 - 2025)

Idexx Laboratories has reported Equity Average over the past 16 years, most recently at $1.6 billion for Q4 2025.

  • Quarterly results put Equity Average at $1.6 billion for Q4 2025, down 1.46% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (down 1.46% YoY), and the annual figure for FY2025 was $1.6 billion, up 3.92%.
  • Equity Average for Q4 2025 was $1.6 billion at Idexx Laboratories, up from $1.5 billion in the prior quarter.
  • Over the last five years, Equity Average for IDXX hit a ceiling of $1.6 billion in Q4 2024 and a floor of $466.5 million in Q3 2022.
  • Median Equity Average over the past 5 years was $1.1 billion (2023), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Equity Average: soared 367.41% in 2021 and later tumbled 37.95% in 2022.
  • Idexx Laboratories' Equity Average stood at $722.7 million in 2021, then dropped by 24.96% to $542.4 million in 2022, then surged by 156.46% to $1.4 billion in 2023, then increased by 15.51% to $1.6 billion in 2024, then dropped by 1.46% to $1.6 billion in 2025.
  • The last three reported values for Equity Average were $1.6 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.